Cluster RCT Protocol Tests Enhanced Early Childhood Development Program in Chinese Primary Care
This publication is a protocol for a cluster randomized controlled superiority trial designed to evaluate an enhanced early childhood development (ECD) program. The study is set in primary health care facilities across 3 counties in China. The target population includes children aged 6-23 months and their families, with a planned sample size of 1044 participants. The intervention consists of a multifaceted enhanced ECD program that includes improved facilities, capacity building for health care providers, age-adapted clinical consultations focusing on nutrition and stimulation, age-specific parenting group sessions, home visits, referrals for children identified as needing additional support, and an electronic data platform to track and coordinate care. The comparator is usual care, which is not further specified in the protocol. The primary outcome is children's overall development as measured by the Global Scale of Early Development combined form at 12 months of follow-up. Secondary outcomes are not reported in this protocol. The total follow-up period is 23 months, with the primary outcome assessed at 12 months. As this is a protocol, no results are available. Safety data, including adverse events, serious adverse events, discontinuations, and tolerability, are not reported. The study is funded in 2023, and ethical approval was obtained from the Institutional Review Board of Shanghai Children's Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine. The protocol notes that the study findings will guide government policies and reforms for strengthening the health system to scale up ECD services. However, because this is a protocol, no comparisons to prior landmark studies can be made, and no methodological limitations or biases are discussed. The clinical implications are not yet known, and many questions remain unanswered until the trial results are published. In summary, this protocol outlines a rigorous cluster randomized trial that may provide valuable evidence on the effectiveness of an enhanced ECD program in a Chinese primary care setting, but no conclusions can be drawn at this time.